Effects of eradication of HCV on cardiovascular risk and preclinical atherosclerosis in HIV/HCV-coinfected patients. Carrero A, Berenguer J, Hontanon V, Navarro J, et al. J Acquir Immune Defic Syndr 2020 Jan 6. doi: 10.1097/QAI.0000000000002260.

Read + Share

Amedeo Smart

Independent Medical Education

Carrero A, Berenguer J, Hontanon V, Navarro J, et al. Effects of eradication of HCV on cardiovascular risk and preclinical atherosclerosis in HIV/HCV-coinfected patients. J Acquir Immune Defic Syndr 2020 Jan 6. doi: 10.1097/QAI.0000000000002260.
PMID: 31913996